Anti-NSDHL antibody [EPR14489(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal NSDHL antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
H105E3, NSDHL, Protein H105e3
- IP
Supplier Data
Immunoprecipitation - Anti-NSDHL antibody [EPR14489(2)] (AB199730)
NSDHL was immunoprecipitated from 1mg of Human fetal brain whole cell lysate with ab199730 at 1/50 dilution.
Lane 1 : Human fetal brain whole cell lysate 10ug (Input).
Lane 2 : ab199730 IP in Human fetal brain whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199730 in Human fetal brain whole cell lysate.
Western blot was performed from the immunoprecipitate using ab199730 at 1/1000 dilution.
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-NSDHL antibody [EPR14489(2)] (ab199730)
Predicted band size: 42 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-NSDHL antibody [EPR14489(2)] (AB199730)
NSDHL was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab199730 at 1/50 dilution.
Lane 1 : HeLa whole cell lysate 10ug (Input).
Lane 2 : ab199730 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199730 in HeLa whole cell lysate.
Western blot was performed from the immunoprecipitate using ab199730 at 1/1000 dilution (Panel A) or ab190353 at 1/1000 dilution (Panel B).
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds (Panel A and B).
ab199730 was used to immunoprecipitate NSDHL. These precipitates were resolved with ab190353.
All lanes:
Immunoprecipitation - Anti-NSDHL antibody [EPR14489(2)] (ab199730)
Predicted band size: 42 kDa
false
- WB
Supplier Data
Western blot - Anti-NSDHL antibody [EPR14489(2)] (AB199730)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-NSDHL antibody [EPR14489(2)] (ab199730) at 1/1000 dilution
Lane 1:
A431 (Human epidermoid carcinoma) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 10 µg
Lane 4:
Human fetal brain tissue lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 5s
- WB
Lab
Western blot - Anti-NSDHL antibody [EPR14489(2)] (AB199730)
Lanes 1-4 : Merged signal (red and green). Green - ab199730 observed at 38 kDa. Red - loading control ab7291 observed at 50 kDa.
ab199730 Anti-NSDHL antibody [EPR14489(2)] was shown to specifically react with NSDHL in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266682 (knockout cell lysate ab258082) was used. Wild-type and NSDHL knockout samples were subjected to SDS-PAGE. ab199730 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-NSDHL antibody [EPR14489(2)] (ab199730) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
NSDHL knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human NSDHL knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-nsdhl-knockout-hek-293t-cell-line-ab266682'>ab266682</a>)
Lane 3:
A431 cell lysate at 20 µg
Lane 4:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 42 kDa
Observed band size: 38 kDa
false
- WB
Supplier Data
Western blot - Anti-NSDHL antibody [EPR14489(2)] (AB199730)
Blocking buffer : 5% NFDM/TBST.
Dilution buffer : 5% NFDM /TBST or 1%BSA /TBST.
All lanes:
Western blot - Anti-NSDHL antibody [EPR14489(2)] (ab199730) at 1/1000 dilution
Lane 1:
NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Lane 3:
C6 (Rat glial tumor cells) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-NSDHL antibody [EPR14489(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NSDHL facilitates the removal of one hydrogen from NAD(P)H and adds it to the steroid precursor lathosterol an important intermediate in cholesterol biosynthesis. Although not part of a larger complex NSDHL performs significant enzymatic steps necessary for converting sterol intermediates. Its activity directly influences sterol composition vital for cell membrane integrity signaling and hormone synthesis.
Pathways
The enzyme plays a critical role in the cholesterol biosynthesis pathway specifically affecting the conversion of lanosterol into cholesterol. NSDHL operates in tandem with other enzymes like DHCR7 influencing the downstream process of sterol maturation. The precise coordination of these enzymes ensures effective cholesterol production essential for maintaining cellular cholesterol levels and systemic lipid homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Immunity, inflammation and disease 11:e829 PubMed37249295
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com